Revolution Medicines, Inc.
RVMD- Exchange
- Nasdaq
- Industry
- Biological Products, (No Diagnostic Substances)
- SEC CIK
- 0001628171
In the last 90 days, Revolution Medicines, Inc. insiders filed 0 open-market purchases and 17 sales; 693 institutions reported holding it in 13F filings for Q2 2026, worth $40.1B in total; Duquesne Family Office is the only superinvestor holding it.
Other share classesRVMDW
13F holders, Q2 2026
Institutional positions in Revolution Medicines, Inc. as of Jun 30, 2026. Investment managers with $100 million or more in US stocks report their long positions on Form 13F within 45 days after each quarter ends. How 13F works
- Institutional holders
- 693
- +182 vs. Q1 2026
- Shares held
- 213.9M
- +25.4M (+13.5%) vs. Q1 2026
- Total value
- $40.1B
- +$22.0B (+121.5%) vs. Q1 2026
- New holders
- 245
- 241 more added
- Sold out
- 63
- 148 more reduced
3 institutions that held it in Q1 2026 haven't filed for Q2 2026 yet. Not filing isn't selling, so they aren't counted as sold out or in the changes above.
Compare with Q1 2026: new holders, sold out and not filed yet
Holders and value by quarter
Institutions reporting RVMD on Form 13F each quarter since Q1 2021, and the total value they reported. Values are as of each quarter end, so they also move with the share price.
| Quarter | Holders | Value |
|---|---|---|
| Q2 2026 | 693 | $40.1B |
| Q1 2026 | 514 | $19.1B |
| Q4 2025 | 387 | $15.9B |
| Q3 2025 | 323 | $8.96B |
| Q2 2025 | 308 | $7.02B |
| Q1 2025 | 284 | $6.83B |
| Q4 2024 | 281 | $8.45B |
| Q3 2024 | 255 | $7.74B |
| Q2 2024 | 223 | $6.54B |
| Q1 2024 | 210 | $5.18B |
| Q4 2023 | 184 | $4.59B |
| Q3 2023 | 168 | $3.11B |
| Q2 2023 | 139 | $2.99B |
| Q1 2023 | 152 | $2.34B |
| Q4 2022 | 135 | $2.10B |
| Q3 2022 | 142 | $1.74B |
| Q2 2022 | 135 | $1.49B |
| Q1 2022 | 126 | $1.89B |
| Q4 2021 | 117 | $1.85B |
| Q3 2021 | 114 | $1.99B |
| Q2 2021 | 130 | $2.23B |
| Q1 2021 | 128 | $3.05B |
Institutions, Q2 2026
Shares, value and share of portfolio for each institution holding Revolution Medicines, Inc.; share changes are against Q1 2026.
| Institution | Shares | Value | % of portfolio | Change in shares | Action |
|---|---|---|---|---|---|
| Nicholas Investment Partners, LP | 244,594 | $45.8M | 2.58% | −16,572−6.3% | Reduced |
| Citigroup Inc | 247,052 | $46.3M | 0.02% | +157,310+175.3% | Added |
| Affinity Asset Advisors, LLC | 250,000 | $46.8M | 2.29% | +150,000+150.0% | Added |
| Chicago Capital, LLC | 251,847 | $47.2M | 1.14% | +251,847 | New |
| Fred Alger Management, LLC | 259,468 | $48.6M | 0.16% | +238,094+1,113.9% | Added |
| Baillie Gifford & Co | 263,466 | $49.3M | 0.04% | +76,394+40.8% | Added |
| Amundi | 269,701 | $50.5M | 0.01% | +131,141+94.6% | Added |
| National Pension Service | 273,604 | $51.2M | 0.03% | +273,604 | New |
| Patient Square Capital LP | 276,000 | $51.7M | 8.01% | +276,000 | New |
| Jennison Associates LLC | 280,933 | $52.6M | 0.03% | −26,444−8.6% | Reduced |
| AIHC Capital Management Ltd | 303,133 | $56.8M | 54.46% | −525,841−63.4% | Reduced |
| Sumitomo Mitsui Trust Holdings, Inc. | 306,300 | $57.4M | 0.03% | +35,328+13.0% | Added |
| 1832 Asset Management L.P. | 309,200 | $57.9M | 0.07% | +309,200 | New |
| Qube Research & Technologies Ltd | 314,365 | $58.9M | 0.07% | −238,925−43.2% | Reduced |
| TCG Crossover Management, LLC | 340,899 | $63.8M | 1.53% | −235,574−40.9% | Reduced |
| Mass General Brigham, Inc | 344,091 | $64.4M | 17.85% | 00.0% | Unchanged |
| California Public Employees Retirement System | 349,929 | $65.5M | 0.04% | +67,969+24.1% | Added |
| General Atlantic LLC | 357,791 | $67.0M | 2.31% | −350,000−49.4% | Reduced |
| Legal & General Group Plc | 381,366 | $71.4M | 0.01% | +40,218+11.8% | Added |
| Duquesne Family Office LLCSuperinvestorDuquesne Family Office | 399,587 | $74.8M | 1.72% | +83,727+26.5% | Added |
| Checkpoint Capital L.P. | 410,353 | $76.9M | 19.72% | +147,814+56.3% | Added |
| First Turn Management, LLC | 415,307 | $77.8M | 8.32% | −53,069−11.3% | Reduced |
| Vestal Point Capital, LP | 450,000 | $84.3M | 1.97% | −1,925,000−81.1% | Reduced |
| Swiss National Bank | 456,331 | $85.5M | 0.04% | +30,900+7.3% | Added |
| Boothbay Fund Management, LLC | 465,787 | $87.2M | 1.67% | +27,192+6.2% | Added |
| Nuveen, LLC | 475,231 | $89.0M | 0.02% | +134,620+39.5% | Added |
| Nationale-Nederlanden Powszechne Towarzystwo Emerytalne S.A. | 479,080 | $89.7M | 4.91% | 00.0% | Unchanged |
| MPM Oncology Impact Management LP | 492,483 | $92.2M | 5.62% | −14,293−2.8% | Reduced |
| Boxer Capital Management, LLC | 500,000 | $93.6M | 7.05% | 00.0% | Unchanged |
| Perceptive Advisors LLC | 527,600 | $98.8M | 1.53% | +269,000+104.0% | Added |
| MIC Capital Management UK LLP | 531,733 | $99.6M | 25.25% | −264,000−33.2% | Reduced |
| BNP Paribas Arbitrage, SA | 552,710 | $103.5M | 0.05% | +130,267+30.8% | Added |
| Candriam Luxembourg S.C.A. | 556,392 | $104.1M | 0.47% | −24,285−4.2% | Reduced |
| DAFNA Capital Management LLC | 562,630 | $105.4M | 20.09% | −18,048−3.1% | Reduced |
| Invesco Ltd. | 578,287 | $108.3M | 0.01% | +185,443+47.2% | Added |
| T. Rowe Price Investment Management, Inc. | 579,382 | $108.5M | 0.07% | −84,665−12.7% | Reduced |
| Citadel Advisors LLC | 589,906 | $110.5M | 0.06% | +189,853+47.5% | Added |
| Adage Capital Partners GP, L.L.C. | 597,226 | $111.8M | 0.16% | −4,878,385−89.1% | Reduced |
| Westfield Capital Management Co LP | 600,821 | $112.5M | 0.37% | −955,757−61.4% | Reduced |
| Bank of New York Mellon Corp | 601,056 | $112.6M | 0.02% | −34,310−5.4% | Reduced |
| Alyeska Investment Group, L.P. | 659,279 | $123.5M | 0.32% | −1,226,542−65.0% | Reduced |
| Polar Capital Holdings Plc | 690,316 | $129.3M | 0.37% | −443,614−39.1% | Reduced |
| Logos Global Management LP | 700,000 | $131.1M | 5.64% | −1,300,000−65.0% | Reduced |
| Two Sigma Investments, LP | 737,697 | $138.2M | 0.10% | −821,110−52.7% | Reduced |
| Dimensional Fund Advisors LP | 763,434 | $143.1M | 0.03% | −81,180−9.6% | Reduced |
| Lord, Abbett & Co. LLC | 789,241 | $147.8M | 0.42% | +655,008+488.0% | Added |
| Morgan Stanley | 838,249 | $157.0M | 0.01% | +132,456+18.8% | Added |
| Deutsche Bank AG | 888,019 | $166.3M | 0.05% | +422,261+90.7% | Added |
| Siren, L.L.C. | 900,000 | $168.6M | 3.42% | −210,980−19.0% | Reduced |
| UBS Asset Management Americas Inc | 912,335 | $170.9M | 0.03% | +411,740+82.3% | Added |
| AH Capital Management, L.L.C. | 921,099 | $172.5M | 1.21% | 00.0% | Unchanged |
| Bank of America Corp | 983,911 | $184.3M | 0.01% | +369,754+60.2% | Added |
| Pictet Asset Management Holding SA | 1,014,894 | $190.8M | 0.18% | +457,334+82.0% | Added |
| Ameriprise Financial Inc | 1,039,702 | $194.7M | 0.04% | −540,091−34.2% | Reduced |
| Bellevue Group AG | 1,048,014 | $196.3M | 4.13% | −496,442−32.1% | Reduced |
| National Bank of Canada | 1,096,025 | $205.3M | 0.18% | −652,975−37.3% | Reduced |
| Rock Springs Capital Management LP | 1,105,210 | $207.0M | 10.10% | −104,255−8.6% | Reduced |
| Northern Trust Corp | 1,117,110 | $209.2M | 0.02% | +162,854+17.1% | Added |
| Vanguard Fiduciary Trust Co | 1,291,141 | $241.8M | 0.05% | +157,822+13.9% | Added |
| AQR Capital Management LLC | 1,295,450 | $242.6M | 0.08% | +1,178,663+1,009.2% | Added |
| Holocene Advisors, LP | 1,359,269 | $254.6M | 0.58% | −1,109,375−44.9% | Reduced |
| Franklin Resources Inc | 1,488,394 | $278.7M | 0.06% | +354,848+31.3% | Added |
| Integral Health Asset Management, LLC | 1,500,000 | $280.9M | 11.53% | 00.0% | Unchanged |
| Charles Schwab Investment Management Inc | 1,917,025 | $359.0M | 0.05% | +181,549+10.5% | Added |
| Caligan Partners LP | 1,961,795 | $367.4M | 17.73% | +308,987+18.7% | Added |
| Woodline Partners LP | 2,002,863 | $375.1M | 1.16% | −503,707−20.1% | Reduced |
| Massachusetts Financial Services Co | 2,012,317 | $376.8M | 0.12% | +2,012,317 | New |
| Nearwater Capital Markets, Ltd | 2,097,000 | $392.7M | 6.77% | +1,419,000+209.3% | Added |
| Goldman Sachs Group Inc | 2,133,101 | $399.5M | 0.04% | −52,399−2.4% | Reduced |
| Norges Bank | 2,157,479 | $404.1M | 0.04% | +2,157,479 | New |
| Avoro Capital Advisors LLC | 2,297,000 | $430.2M | 3.86% | −47,444−2.0% | Reduced |
| Price T Rowe Associates Inc | 2,390,303 | $447.7M | 0.04% | −841,910−26.0% | Reduced |
| Deerfield Management Company, L.P. (Series C) | 2,392,000 | $448.0M | 4.67% | +95,000+4.1% | Added |
| Casdin Capital, LLC | 2,577,333 | $482.7M | 24.16% | 00.0% | Unchanged |
| Alphabet Inc. | 2,946,619 | $551.8M | 0.56% | −345,906−10.5% | Reduced |
| BVF Inc | 2,965,160 | $555.3M | 14.20% | +108,378+3.8% | Added |
| JPMorgan Chase & Co | 3,298,066 | $636.9M | 0.04% | +2,996,673+994.3% | Added |
| Wellington Management Group LLP | 3,843,415 | $719.8M | 0.12% | −2,184,404−36.2% | Reduced |
| Geode Capital Management, LLC | 3,942,676 | $736.8M | 0.04% | +604,534+18.1% | Added |
| Capital World Investors | 4,008,244 | $750.7M | 0.09% | +4,008,244 | New |
| State Street Corp | 4,897,051 | $917.1M | 0.03% | +494,389+11.2% | Added |
| UBS Group AG | 5,448,364 | $1.02B | 0.16% | +1,061,573+24.2% | Added |
| Paradigm Biocapital Advisors LP | 6,361,323 | $1.19B | 22.31% | −294,380−4.4% | Reduced |
| Nextech Invest, Ltd. | 7,601,087 | $1.42B | 67.55% | 00.0% | Unchanged |
| Vanguard Portfolio Management LLC | 8,294,855 | $1.55B | 0.07% | +792,232+10.6% | Added |
| Vanguard Capital Management LLC | 9,088,661 | $1.70B | 0.04% | +726,377+8.7% | Added |
| Jupiter Topco LLC | 10,736,145 | $2.01B | 0.82% | +10,736,145 | New |
| Darwin Global Management, Ltd. | 10,629,822 | $2.05B | 54.45% | +8,418,804+380.8% | Added |
| Baker Bros. Advisors LP | 11,443,357 | $2.14B | 10.74% | +1,888,000+19.8% | Added |
| FMR LLC | 12,200,422 | $2.28B | 0.10% | +3,736,108+44.1% | Added |
| Farallon Capital Management, L.L.C. | 13,550,796 | $2.54B | 14.86% | −54,000−0.4% | Reduced |
| BlackRock, Inc. | 13,695,790 | $2.56B | 0.04% | +2,483,084+22.1% | Added |
| ABS Investment Management LLC | 187 | – | – | +187 | New |
| Frazier Life Sciences Management, L.P. | 0 | $0 | 0.00% | −675,686−100.0% | Sold out |
| Lunate Capital Ltd | 0 | $0 | 0.00% | −549,050−100.0% | Sold out |
| Voloridge Investment Management, LLC | 0 | $0 | 0.00% | −368,325−100.0% | Sold out |
| Ikarian Capital, LLC | 0 | $0 | 0.00% | −163,142−100.0% | Sold out |
| Squarepoint Ops LLC | 0 | $0 | 0.00% | −120,769−100.0% | Sold out |
| Verition Fund Management LLC | 0 | $0 | 0.00% | −110,000−100.0% | Sold out |
| Connor, Clark & Lunn Investment Management Ltd. | 0 | $0 | 0.00% | −91,720−100.0% | Sold out |